John K Chan

6PUBLICATIONS
55CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 11, 2025
Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma.

Robert L Hollis, Austin Miller, Heather A Lankes

|Apr 07, 2025
Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial.

Jung-Min Lee, Austin Miller, Peter G Rose

|Apr 07, 2023
Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation: Results From the TAPUR Study.

Eugene R Ahn, Michael Rothe, Pam K Mangat

|Dec 24, 2021
The Healthcare Journey of Women With Advanced Gynecological Cancer From Diagnosis Through Terminal Illness: Qualitative Analysis of Progress Note Data.

Ellis C Dillon, Vidita Chopra, Elizabeth Mesghina

|Oct 20, 2020
Uterine clear cell carcinoma risk in White versus non-White US subpopulations: does race matter?

Stephanie Chow, Deanna Wong, Cheng I Liao

|Jul 08, 2020
Trends in the Utilization of Palliative Care in Patients With Gynecologic Cancer Who Subsequently Died During Hospitalization.

Anthony Milki, Amandeep Kaur Mann, Austin Gardner

Pageof 1

Frequent Collaborators

2 joint publications

Kathleen N Moore

2 joint publications

Peter G Rose

2 joint publications

Austin Miller

1 joint publications

David M Gershenson